Imidazole → HCID 22228535, compound
Reaction equation
Br[CH2:2][CH2:3][CH2:4][C:5]1[CH:10]=[CH:9][C:8]([S:11]([NH:14][C:15]2[CH:16]=[CH:17][CH:18]=[C:19]3[C:23]=2[NH:22][CH:21]=[C:20]3[Cl:24])(=[O:13])=[O:12])=[CH:7][CH:6]=1.[NH:25]1[CH:29]=[CH:28][N:27]=[CH:26]1.CN(C)C=O>O>[Cl:24][C:20]1[C:19]2[C:23](=[C:15]([NH:14][S:11]([C:8]3[CH:9]=[CH:10][C:5]([CH2:4][CH2:3][CH2:2][N:25]4[CH:29]=[CH:28][N:27]=[CH:26]4)=[CH:6][CH:7]=3)(=[O:13])=[O:12])[CH:16]=[CH:17][CH:18]=2)[NH:22][CH:21]=1Participants
5
Reactant 3
Product 1
Reagents, catalysts & solvents 1
Conditions
- Temperature
- 80 °C
Procedure
To 4-(3-bromopropyl)-N-(3-chloro-1H-indole-7-yl)benzenesulfonamide (213 mg, 0.5 mmol) were added 170 mg (2.5 mmol) of imidazole and 6 ml of dimethylformamide, followed by heating at 80° C. for 3 hours in a nitrogen atmosphere. Then, the reaction mixture was poured into water and extracted with chloroform. The extract was dried over magnesium sulfate and concentrated. Then, the residue was purified by silica gel column chromatography, to give 160 mg of the title compound.
Workup
- extractionextracted with chloroform
- dry with materialThe extract was dried over magnesium sulfate
- concentrationconcentrated
- customThen, the residue was purified by silica gel column chromatography
Sources & evidence
- ORD record
- ord-a70db7919b8748189304bcaec9f77672
- Source dataset
- uspto-grants-2010_11
- Patent number
- US07834049B2
Reaction notes
Loading…